outcome of board meeting
CAPILLARY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Capillary Technologies India Limited reported audited standalone financial results for FY2026 ending March 31, 2026. Revenue from operations grew 22% year-over-year to ₹2,118.90 million from ₹1,740.91 million, with Q4 FY26 revenue at ₹650.23 million showing stronger 31% YoY growth. However, full-year profit before tax declined 17.6% to ₹28.90 million from ₹35.06 million, though Q4 alone showed robust profitability of ₹98.95 million. Total expenses increased to ₹1,724.74 million, driven largely by higher employee costs of ₹1,225.96 million (up from ₹959.34 million). The company listed on BSE and NSE in November 2025 via IPO, raising ₹3,229.08 million net of expenses, with most proceeds (₹3,228.95 million) still held in fixed deposits as of March 2026. Statutory auditors Walker Chandiok & Co. LLP issued an unmodified opinion, and M/s. Protiviti India Member Private Limited was appointed as internal auditors for FY2026-27.
Strong revenue growth demonstrates business momentum, but declining full-year profitability amid rising costs may concern investors. The large unutilized IPO proceeds provide significant firepower for future acquisitions or growth investment. Trading window reopening after 48 hours of results declaration could trigger increased stock activity.